BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16886653)

  • 41. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.
    Li J; Chen P; Dai CH; Li XQ; Bao QL
    Geriatr Gerontol Int; 2009 Jun; 9(2):172-82. PubMed ID: 19740361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
    J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms.
    Merritt RE; Mathisen DJ; Wain JC; Gaissert HA; Donahue D; Lanuti M; Allan JS; Morse CR; Wright CD
    Ann Thorac Surg; 2009 Nov; 88(5):1574-81; discussion 1581-2. PubMed ID: 19853115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy.
    Sekine I; Sumi M; Ito Y; Tanai C; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Jpn J Clin Oncol; 2009 Nov; 39(11):707-12. PubMed ID: 19692418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer.
    Berthelet E; Truong PT; Lesperance M; Lim JT; Wai ES; MacNeil MV; Liu M; Joe H; Olivotto IA
    Am J Clin Oncol; 2006 Feb; 29(1):21-6. PubMed ID: 16462498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lung cancer in patients younger than 40 years in a multiracial Asian country.
    Liam CK; Lim KH; Wong CM
    Respirology; 2000 Dec; 5(4):355-61. PubMed ID: 11192546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].
    Yi SZ; Zhang DC; Wang YG; Sun KL
    Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Population variations in the initial treatment of non-small-cell lung cancer.
    Potosky AL; Saxman S; Wallace RB; Lynch CF
    J Clin Oncol; 2004 Aug; 22(16):3261-8. PubMed ID: 15310770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors for patients with spinal metastases from lung cancer.
    Ogihara S; Seichi A; Hozumi T; Oka H; Ieki R; Nakamura K; Kondoh T
    Spine (Phila Pa 1976); 2006 Jun; 31(14):1585-90. PubMed ID: 16778693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer.
    Mac Manus MP; Matthews JP; Wada M; Wirth A; Worotniuk V; Ball DL
    Cancer; 2006 Mar; 106(5):1110-6. PubMed ID: 16432830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinico-pathologic and prognostic studies on lung adenocarcinoma patients under 40 years of age].
    Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Zhao S
    Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):157-9. PubMed ID: 12795843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
    Jennens RR; Giles GG; Fox RM
    Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prognostic Relevance of the Metastatic Localisation in Patients with Stage IV NSCLC - Results of a Prospective Epidemiological Study].
    Blankenburg T; Gottschlich B; Schütte W; Neef H; Haerting J
    Pneumologie; 2010 Nov; 64(11):679-85. PubMed ID: 20577949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex differences in survival in non-small cell lung cancer patients 1974-1998.
    Moore R; Doherty D; Chamberlain R; Khuri F
    Acta Oncol; 2004; 43(1):57-64. PubMed ID: 15068321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [In which stage we diagnose and how we treat lung cancer?].
    Oztuna F; Ozlü T; Bülbül Y
    Tuberk Toraks; 2003; 51(2):152-6. PubMed ID: 15143421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastric cancer in the young.
    Lai IR; Lee WJ; Chen CN; Lee PH; Chang KJ; Chang-Yu S; Chen KM
    Hepatogastroenterology; 1997; 44(18):1641-5. PubMed ID: 9427036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wait times in diagnostic evaluation and treatment for patients with stage III non-small cell lung cancer in British Columbia.
    Wai ES; Mackinnon M; Hooker R; Moccia P; Perry KR; Truong PT
    Am J Clin Oncol; 2012 Aug; 35(4):373-7. PubMed ID: 21422900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lung cancer in patients under 40 years of age: a different problem?].
    Feliu J; González Barón M; Berrocal A; Barón Saura JM; Artal A; Garrido P; Ordóñez A; Jalón JI
    Med Clin (Barc); 1991 Sep; 97(10):373-6. PubMed ID: 1660555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.